squamous cell carcinoma of the esophagus
Showing 1 - 6 of 6
Advanced Solid Tumor, Colorectal Cancer, Lung Cancer Trial in Randwick (KF-0210 tablets, 120 mg, KF-0210 tablets, 240 mg,
Recruiting
- Advanced Solid Tumor
- +5 more
- KF-0210 tablets, 120 mg
- +6 more
-
Randwick, New South Wales, AustraliaScientia Clinical Research Limited
Aug 31, 2021
Adenocarcinoma of the Esophagus, Adenocarcinoma of the Gastroesophageal Junction, Diffuse Adenocarcinoma of the Stomach Trial in
Terminated
- Adenocarcinoma of the Esophagus
- +13 more
- oblimersen sodium
- +2 more
-
Bronx, New YorkMontefiore Medical Center
Jan 29, 2021
Adenocarcinoma of the Esophagus, Adenocarcinoma of the Gastroesophageal Junction, Adenocarcinoma of the Stomach Trial in
Completed
- Adenocarcinoma of the Esophagus
- +7 more
- erlotinib hydrochloride
- +10 more
-
Winston-Salem, North CarolinaWake Forest University Health Sciences
Jun 29, 2018
Adenocarcinoma of the Esophagus, Adenocarcinoma of the Gastroesophageal Junction, Squamous Cell Carcinoma of the Esophagus Trial
Withdrawn
- Adenocarcinoma of the Esophagus
- +2 more
- Monalizumab
- +4 more
-
Brussels, BelgiumInstitut Jules Bordet
Dec 18, 2017
Adenocarcinoma of the Esophagus, Adenocarcinomas of the Gastroesophageal Junction, Recurrent Esophageal Cancer Trial in Columbus
Completed
- Adenocarcinoma of the Esophagus
- +4 more
- pralatrexate
- +3 more
-
Columbus, OhioOhio State University
Apr 25, 2016
Adenocarcinoma of the Esophagus, Adenocarcinoma of the Gastroesophageal Junction, Recurrent Esophageal Cancer Trial in New York
Completed
- Adenocarcinoma of the Esophagus
- +5 more
- erlotinib hydrochloride
- laboratory biomarker analysis
-
New York, New YorkMemorial Sloan-Kettering Cancer Center
Jun 3, 2013